News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Since $Timothy $G. $Dixon's riding ($Ego) mower keeps reappearing on the $TSOI board here 
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175066730
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176384973&txt2find=importance
Company Officers & Contacts
Timothy G. Dixon President, CEO
Board of Directors
Timothy G. Dixon President, CEO
Thomas E. Ichim, Ph.D
Since $Timothy $G. $Dixon's riding ($Ego) mower had to reappear on the $TSOI board here
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176319986&txt2find=mower
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401
at least still trading.
Good .0001 play. They saving it.
Buying. What happening?
$Timothy $G $Dixon $Thomas $ $Ichim
Since $Timothy $G. $Dixon's riding (Ego) mower had to reappear on the $TSOI board here
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401&txt2find=EUA
The more it's shows up publicly it helps keep his name search engine friendly & highly ranked shall we say.
So let's also not forget $Thomas $Ichim
$Therapeutic $Solutions $International $Inc
So if when any want to continually bitch, complain, or simply report to the proper authorities as (plenty quotes & screenshots publicly available of) for both Timothy G Dixon & Thomas Ichim
Right
Let’s not forget Thomas Ichim”s intellect
Since $Timothy $G. $Dixon's riding (Ego) mower had to reappear on the $TSOI board here
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171678401&txt2find=EUA
The more it's shows up publicly it helps keep his name search engine friendly & highly ranked shall we say.
So let's also not forget $Thomas $Ichim
$Therapeutic $Solutions $International $Inc
So if when any want to continually bitch, complain, or simply report to the proper authorities as (plenty quotes & screenshots publicly available of) for both Timothy G Dixon & Thomas Ichim
$TSOI
Timothy G. Dixon President, CEO
Will TSOI and others be changed into new one?
Set up TSOI account at https://wildrosehc.com. What is the next?
|
Followers
|
517
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
66889
|
|
Created
|
10/04/08
|
Type
|
Free
|
| Moderators BigBadWolf johnnytrader33 JMC$ Yooperman Hogwarts | |||
Preclinical Data Suggests QuadraMune™ Prevents Stress-Induced Suppression of Neurogenesis More Effectively than Prozac
OCEANSIDE, Calif., Dec. 9, 2020 /PRNewswire/ -- Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today new data suggesting the possibility that QuadraMune™ may mediate neuroprotective activity through preserving the ability of regenerative brain cells to proliferate subsequent to psychological stress.
The experiments, which involved exposing mice to established stressors, demonstrated that specific areas of the brain associated with production of new brain cells are damaged by stress. In agreement with previously published research, administration of fluoxetine (Prozac™) protected the brain from stress-induced damage. Surprisingly, QuadraMune™ administration appeared superior to Prozac™ at stimulating proliferation of new brain cells.
"QuadraMune™ which is currently in a clinical trial for prevention of COVD-191, has also been demonstrated to possess anti-inflammatory activity in other clinical trials, suppressing cytokines such as IL-62, which are known to be involved in depression3 and suicide4" said Kalina O'Connor, Director of Campbell Neurosciences and co-inventor on the patent. "Given major depressive disorder causes a significant risk for suicide, we are highly interested in exploring the use of QuadraMune™ for preventing suicide."
"Although much enthusiasm has been generated over the planned distribution of the COVID vaccine, at present little is being done to address mental health issues that are being exacerbated by the current pandemic" said Dr. James Veltmeyer, co-inventor of the patent, and Chief Medical Officer of the Company. "If current results are reproducible, the possibility that a nutraceutical would concurrently boost immunity while preserving mental health is highly enticing."
"It has not escaped us that COVID-19 is associated with increased inflammatory cytokines in the blood of patients, cytokines that also predispose to depression" said Famela Ramos, Vice President of Business Development for the Company. "It may be that the recent increase in suicides and suicide attempts is related biologically to activities of the coronavirus. It will be interesting to examine whether QuadraMune™ may modify putative negative mental effects of the virus."
"An estimated 17.3 million adults in the United States had at least one major depressive episode. This number represented 7.1% of all U.S. adults" stated Timothy Dixon, President and CEO of the Company. "We believe the Mission of our Company is not just providing a return on investment to our shareholders, but also increasing the quality of life for Americans. We are extremely pleased to report this unexpected finding with significant potential implications to advancing non-toxic means of helping patients with this terrible condition."
1 QuadraMune(TM) for Prevention of COVID-19 - Full Text View - ClinicalTrials.gov
2 Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune™, Designed to Protect Against COVID-19 | BioSpace
3 Ting et al. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020 Mar 22;21(6):2194.
4 O'Donovan et al. Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety. 2013 Apr;30(4):307-14.
“Stem Cell Therapy ; Authorizes allopathic physicians & osteopathic physicians to perform stem cell therapy not approved by United States Food & Drug Administration; …”
As of August 19, 2024, 4,884,095,275 shares of the registrant’s common stock, par value of $0.001 per shares, were outstanding.
Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.
The securities Purchase Agreement (section 1(u)) also contains a provision for a discount rate different from above in the event we were to uplist to a National Exchange, as that meaning is defined in the Act. The Company has no plans to uplist in the foreseeable future, if ever.
The Common Stock is quoted on the OTC Markets, under the symbol “TSOI.” On January 30, 2024, the last reported sale price of the Common Stock on the OTC Markets was $0.00105 per share
@ the bottomTHERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Date: August 21, 2023
By: /s/ Timothy G. Dixon
Timothy G. Dixon
President and Chief Executive Officer
(Principal Executive Officer)
Officers (like the CEO) and members of the Board of Directors can absolutely still be sued personally—even after the company delists and goes private. Here's how it works:
Delisting Doesn’t Grant Immunity
Just because a company delists from a stock exchange or goes private doesn't shield its executives or board members from legal liability for actions taken while the company was public. Key points:
Securities fraud and breach of fiduciary duty claims typically relate to conduct that occurred while the company was public.
These claims remain valid even after the company goes private or delists.
Delisting might make it harder to monitor future misconduct, but past misconduct is still fully actionable.
They Be Sued Personally with Limits
You can sue individual directors and officers for things like:
Securities fraud (e.g., knowingly misleading shareholders)
Breach of fiduciary duty
Self-dealing or insider trading
Negligence or gross mismanagement
Going Private Doesn’t “Erase” Liability
Even if the company is taken private through a buyout (e.g., private equity), this does not erase previous misconduct or prevent lawsuits.
In fact, going private can sometimes trigger additional lawsuits—especially if:
The buyout undervalues the company (minority shareholders may sue for unfair treatment).
The deal is structured to shield insiders or hide prior fraud.
Red Flags That Strengthen Your Case
Officers issued themselves new shares while misleading investors
Press releases or filings overstated product potential, partnerships, or financial position
Officers sold shares before bad news was revealed...[color=red][/color]
Going private was timed to avoid further disclosure or lawsuits
Idaho properties bought as supposed company property yet only used as a mailing address or for personal use up & until going private would be a serious allegation — and if substantiated, it could be grounds for personal liability, civil fraud, and possibly even criminal charges against the CEO.
Summary: This May Be Embezzlement, Fraud, or Breach of Fiduciary Duty
If the CEO used company funds (investor/shareholder capital) to buy personal vacation or retirement properties, that could constitute:
Misappropriation of corporate assets
Using corporate funds for personal use — without legitimate compensation or board approval — is a clear breach of fiduciary duty.
Self-dealing
Directing corporate funds for personal gain without disclosure or shareholder consent is illegal and unethical.
Fraud
If this spending was hidden, mischaracterized in financial statements, or not disclosed to investors, it may constitute securities fraud or wire fraud, depending on how the funds moved.
Possible criminal liability
This goes beyond civil liability. If you have proof (documents, emails, public records of real estate transactions, etc.), this could be referred to:
The SEC (for public companies)
The Department of Justice (for criminal fraud)
State Attorney General or Securities Regulator
What The Idaho Corporate Properties Likely Constitutes:
1. Corporate Embezzlement
The CEO has misused company funds for personal benefit. This is theft, not just mismanagement.
2. Breach of Fiduciary Duty
CEOs owe a duty of loyalty and care to shareholders. Using company funds for personal enrichment is a blatant breach.
3. Fraud and Misrepresentation
If the CEO concealed this behavior from shareholders, the SEC, or other stakeholders (or misrepresented it in filings), this is securities fraud—possibly wire fraud too.
4. Unjust Enrichment
Even if the company delists or goes private, this personal enrichment can be challenged and possibly reversed through civil lawsuits or asset recovery.
Impact of Company Going Private:
The CEO may believe that delisting means he escapes scrutiny. That’s false. If the misconduct occurred while the company was public or using investor money, it:
Remains fully actionable
Can be prosecuted or sued over regardless of public/private status
Could trigger personal liability and asset seizure
Courts can issue:
Civil judgments to return stolen funds or assets
Freezing orders or liens on misappropriated property
Criminal asset forfeiture, in extreme cases[/color]
What the statements relayed publicly from the CEO regarding the Idaho properties likely means legally:
The CEO’s explanation — that the properties were bought "to avoid California laws that were never implemented", but he personally uses the property in Idaho while the business remains operational and leased in California — adds multiple new legal issues:
The Above Points to Clear Fraud, Waste, and Self-Dealing
1. Pretextual Justification (False Business Purpose)
Claiming a business justification for purchasing real estate with company funds — then using it personally — is a fraudulent misuse of corporate assets.
The fact that the laws were never implemented and the business is still operating in California kills any credibility to the explanation.
2. Personal Use = Conversion of Corporate Property
If the Idaho property was purchased using company/investor funds but is being used personally for non-business purposes (e.g., trout fishing, leisure), this is potentially:
Conversion (civil theft)
Unjust enrichment
Breach of fiduciary duty
Possibly tax fraud if it was written off as a business expense
3. Waste of Corporate Assets
The CEO made an investment of company capital with no clear business value, and is enjoying personal benefits while shareholders carry the loss.
Courts can rule that this is corporate waste and order repayment or asset forfeiture.[/color]
You Now Have a Strong Civil and Possibly Criminal Case & your case would be strengthened by
A regulatory complaint to the SEC, CA Attorney General, or Idaho AG
AI
_(TSOI)_-_Trades_-_ADVFN.png)
